The pathogenesis of Barrett’s esophagus: A process in Continuum or discontinuum Rebecca C. FitzgeraldMichael J. G. Farthing OriginalPaper Pages: 421 - 424
Clinical pharmacology of inflammatory bowel disease therapies William J. SandbornWilliam A. Faubion OriginalPaper Pages: 440 - 445
Medical therapies for ulcerative colitis and crohn’s disease Filip J. BaertPaul J. Rutgeerts OriginalPaper Pages: 446 - 450
Neoplastic and other complications of inflammatory bowel disease Charles N. Bernstein OriginalPaper Pages: 451 - 459
Maintenance therapies for crohn’s disease: Steroid dependence and delaying postoperative recurrence Stephen B. Hanauer Clinical Trials Report Pages: 460 - 460
Adjuvant therapy for gastric cancer: A reality at last J. Randolph Hecht OriginalPaper Pages: 478 - 481
Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole Alan B. R. Thomson OriginalPaper Pages: 482 - 493
A critical review of the effect of Helicobacter pylori eradication on gastric MALT lymphoma Andrew C. Wotherspoon OriginalPaper Pages: 494 - 498